Submission Details
| 510(k) Number | K964185 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 21, 1996 |
| Decision Date | November 04, 1997 |
| Days to Decision | 379 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K964185 is an FDA 510(k) clearance for the IMX CA 125, a Test, Epithelial Ovarian Tumor-associated Antigen (ca125) (Class II — Special Controls, product code LTK), submitted by Abbott Diagnostics (Abbott Park, US). The FDA issued a Cleared decision on November 4, 1997, 379 days after receiving the submission on October 21, 1996. This device falls under the Immunology review panel. Regulated under 21 CFR 866.6010.
| 510(k) Number | K964185 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 21, 1996 |
| Decision Date | November 04, 1997 |
| Days to Decision | 379 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | LTK — Test, Epithelial Ovarian Tumor-associated Antigen (ca125) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.6010 |